Live Breaking News & Updates on Dream Project

Stay updated with breaking news from Dream project. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

$400,000 Casio G-Shock watch shows AI can create beautiful design

And it s ridiculously extravagant. ....

Casiog Shockg D , Apple Watch Series , Dream Project , Apple Watch Ultra ,

G-SHOCK Made with AI, 18-Karat Gold Sells for a Whopping $400K

What's all gold, half-designed by artificial intelligence, and costs nearly a half million dollars? Believe it or not, it's a G-SHOCK. ....

New York , United States , Kikuo Ibe , Louis Vuitton , Pharrell William , New York Times , New York City , Philips Auction House , Nature Conservancy , Karat Gold , Dream Project ,

Enduring toughness: G-Shock's 40th anniversary spectacle and legacy

Enduring toughness: G-Shock's 40th anniversary spectacle and legacy
mb.com.ph - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mb.com.ph Daily Mail and Mail on Sunday newspapers.

Jawa Timur , Kikuo Ibe , Southeast Asia , G Shockg D , Dream Project , Warren Hue , Shock The World ,

Here's How G-Shock Celebrated Its 40th Anniversary Last Weekend!

The company commemorated its 40-year journey of innovation and resilience with its Shock The World celebration at Bali last weekend. ....

Jawa Timur , Jakarta Raya , High School , Shock The World , John Peter , Dream Project , Warren Hue , Chance With ,

Kura Oncology's Menin Inhibitor Ziftomenib Selected for The Leukemia & Lymphoma Society's Pediatric Acute Leukemia (PedAL) Master Clinical Trial

SAN DIEGO, Dec. 08, 2023 (GLOBE NEWSWIRE) Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, and The Leukemia & Lymphoma Society (LLS), the largest private funder of blood cancer research, today announced a clinical collaboration to evaluate Kura’s menin inhibitor, ziftomenib, in combination with chemotherapy in pediatric patients with relapsed/refractory KMT2A-rearranged, NUP98- ....

New Zealand , United States , Gwen Nichols , Alexandra Weingarten , Ryan Mcdonald , Mollie Leoni , Kura Oncology Inc , Science Communications , Drug Administration , Fast Company , Leukemia Lymphoma Society , Exchange Commission , Clinical Development , Information Resource Center , Corporate Communications , Lymphoma Society , Executive Vice President , North America , Pediatric Oncology , Pediatric Acute Leukemia , Dream Project , Chief Medical Officer , Orphan Drug Designation , Pediatric Acute Leukemia Master Trial , Screening Trial , Rye Brook ,